---
title: "Core Scientifc - CW27 | 8-K: FY2025 Q2 Revenue: USD 78.63 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252286980.md"
datetime: "2025-08-08T20:26:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252286980.md)
  - [en](https://longbridge.com/en/news/252286980.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252286980.md)
generator: "portal-rs"
---

# Core Scientifc - CW27 | 8-K: FY2025 Q2 Revenue: USD 78.63 M

Revenue: As of FY2025 Q2, the actual value is USD 78.63 M.

EPS: As of FY2025 Q2, the actual value is USD -0.04.

### Segment Revenue

-   **Total Revenue**: $78.6 million, down from $141.1 million in the second quarter of 2024.
-   **Digital Asset Self-Mining Revenue**: $62.4 million, a decrease from $110.7 million in the prior-year period, primarily due to a 62% decrease in bitcoin mined, partially offset by a 50% increase in the average bitcoin price.
-   **Digital Asset Hosted Mining Revenue**: $5.6 million, down from $24.8 million, driven by a strategic shift to colocation business.
-   **Colocation Revenue**: $10.6 million, up from $5.5 million, due to expansion into Denton, Texas.

### Operational Metrics

-   **Gross Profit**: $5.0 million, compared to $38.8 million in the same period last year.
-   **Net Loss**: - $936.8 million, compared to - $804.9 million in the prior-year period, primarily due to non-cash fair value adjustments related to warrants and contingent value rights.
-   **Adjusted EBITDA**: $21.5 million, down from $46.0 million for the prior year period.

### Cash Flow

-   **Liquidity Position**: $754.1 million, including $581.3 million of cash and cash equivalents and $172.8 million of digital assets at the end of the second quarter of 2025.

### Unique Metrics

-   **Capital Expenditures**: $121.3 million, with $90.3 million funded by CoreWeave under contractual agreements, and $31.0 million spent on new site development at non-CoreWeave locations.

### Outlook / Guidance

-   Core Scientific is in the process of being acquired by CoreWeave in an all-stock transaction, subject to stockholder and regulatory approvals. Each share of Core Scientific’s common stock will be converted into CoreWeave Class A common stock at an exchange ratio of 0.1235.

### Related Stocks

- [CORZW.US](https://longbridge.com/en/quote/CORZW.US.md)

## Related News & Research

- [ANALYSIS-Depleted US oil stash loses potency as Iran war grinds on](https://longbridge.com/en/news/297496754.md)
- ['This Changes Everything,' Says Investor About Palantir Stock](https://longbridge.com/en/news/297515312.md)
- [The Calmer Co. Details ASX Governance Compliance in Appendix 4G Filing](https://longbridge.com/en/news/297454626.md)
- [China's CXMT makes breakthrough in advanced memory chips, the Information reports](https://longbridge.com/en/news/297536166.md)
- [Greg Abel Just Gave Investors $4.5 Billion Reasons to Take a Closer Look at Berkshire Hathaway](https://longbridge.com/en/news/297536396.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**